Jane Street’s BELLUS Health Inc. BLU Stock Holding History

Jane Street’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,000	Closed	-$230K	–	9915
2023 Q1	$230K	Buy	+32,000	New	+$248K	﹤0.01%	7627
2022 Q3	–	Sell	-13,000	Closed	-$120K	–	10773
2022 Q2	$120K	Sell	13,000 -11,000	-46%	-$90K	﹤0.01%	8535
2022 Q1	$166K	Sell	24,000 -23,200	-49%	-$149K	﹤0.01%	9161
2021 Q4	$380K	Buy	+47,200	New	+$313K	﹤0.01%	7750

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Jane Street's BLU Position: Q2 2023 in Review

Jane Street sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 26,039 shares — an estimated $187K sold.

Jane Street first reported a position in BLU in Q4 2020 and held it in 7 quarters. The position peaked at $893K in Q2 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Jane Street reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Jane Street sold 26,039 BELLUS Health Inc. shares in Q2 2023, an estimated $187K.
Jane Street first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 7 quarters.
Jane Street's BELLUS Health Inc. position peaked at $893K in Q2 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.